Directed evolution of adeno-associated virus for glioma cell transduction

Journal of Neuro-Oncology

Volumn 96, Issue 3, 2010, Pages 337-347

  Maguire, Casey A ^a   Gianni, Davide ^a,b   Meijer, Dimphna H ^c   Shaket, Lev A ^a   Wakimoto, Hiroaki ^a   Rabkin, Samuel D ^a   Gao, Guangping ^d   Sena Esteves, Miguel ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Adeno associated virus (AAV); Brain tumor; Gene therapy; Gene transfer; Glioblastoma; Library

Indexed keywords

CAPSID PROTEIN; PARVOVIRUS VECTOR; VIRUS PROTEIN;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ARTICLE; CELL SELECTION; CHIMERA; CONTROLLED STUDY; EVOLUTION; FLUORESCENCE; GENETIC TRANSDUCTION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; MOUSE; NONHUMAN; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID;

CAPSID PROTEINS; CELL LINE, TUMOR; DEPENDOVIRUS; DNA SHUFFLING; FLOW CYTOMETRY; GENE LIBRARY; GENETIC VECTORS; GLIOMA; GREEN FLUORESCENT PROTEINS; HEPARIN; HUMANS; NEUROBLASTOMA; TIME FACTORS; TRANSDUCTION, GENETIC;

EID: 75049084578     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9972-7     Document Type: Article

References (40)

1. M Wrensch Y Minn T Chew M Bondy MS Berger 2002 Epidemiology of primary brain tumors: current concepts and review of the literature Neurooncology 4 278 299
2. KE Wallner JH Galicich G Krol E Arbit MG Malkin 1989 Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma Int J Radiat Oncol Biol Phys 16 1405 1409 1:STN:280:DyaL1M3lsVKmtw%3D%3D 2542195
3. LA Stewart 2002 Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet 359 1011 1018 10.1016/S0140-6736(02)08091-1 1:CAS:528: DC%2BD38XisV2htro%3D 11937180 (Pubitemid 34286538)
4. J Yoshida M Mizuno N Nakahara P Colosi 2002 Antitumor effect of an adeno-associated virus vector containing the human interferon-beta gene on experimental intracranial human glioma Jpn J Cancer Res 93 223 228 1:CAS:528:DC%2BD38XislGhtLY%3D 11856487
5. M Mizuno J Yoshida P Colosi G Kurtzman 1998 Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration Jpn J Cancer Res 89 76 80 1:CAS:528: DyaK1cXntVCnsA%3D%3D 9510479
6. PC Huszthy A Svendsen JM Wilson RM Kotin PE Lonning R Bjerkvig F Hoover 2005 Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human glioblastoma multiforme xenografts Hum Gene Ther 16 381 392 10.1089/hum.2005.16.381 1:CAS:528:DC%2BD2MXivFWltrc%3D 15812233 (Pubitemid 40471898)
7. TC Harding PJ Dickinson BN Roberts S Yendluri M Gonzalez-Edick RA Lecouteur KU Jooss 2006 Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors Hum Gene Ther 17 807 820 10.1089/hum.2006.17.807 1:CAS:528: DC%2BD28XovVygs7w%3D 16942441 (Pubitemid 44681451)
8. DA Reardon PY Wen 2006 Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents Oncologist 11 152 164 10.1634/theoncologist.11-2-152 1:CAS:528:DC%2BD28XhtFKqsbvN 16476836 (Pubitemid 43261762)
9. G Wollmann P Tattersall AN van den Pol 2005 Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential J Virol 79 6005 6022 10.1128/JVI.79.10.6005-6022.2005 1:CAS:528:DC%2BD2MXkt1Wit7s%3D 15857987 (Pubitemid 40617207)
10. F Thorsen S Afione PC Huszthy BB Tysnes A Svendsen R Bjerkvig RM Kotin PE Lonning F Hoover 2006 Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma J Gene Med 8 1131 1140 10.1002/jgm.939 1:CAS:528:DC%2BD28XhtFeit7bK 16810631 (Pubitemid 44488036)
11. M Grifman M Trepel P Speece LB Gilbert W Arap R Pasqualini MD Weitzman 2001 Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids Mol Ther 3 964 975 10.1006/mthe.2001.0345 1:CAS:528: DC%2BD38XhvFKitLw%3D 11407911 (Pubitemid 32611306)
12. A Girod M Ried C Wobus H Lahm K Leike J Kleinschmidt G Deleage M Hallek 1999 Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2 Nat Med 5 1052 1056 10.1038/71021 1:CAS:528:DyaK1MXlslGqtb8%3D 10470084
13. H Buning MU Ried L Perabo FM Gerner NA Huttner J Enssle M Hallek 2003 Receptor targeting of adeno-associated virus vectors Gene Ther 10 1142 1151 10.1038/sj.gt.3301976 1:STN:280:DC%2BD3szgsVWktw%3D%3D 12833123 (Pubitemid 36896589)
14. LM Work H Buning E Hunt SA Nicklin L Denby N Britton K Leike M Odenthal U Drebber M Hallek AH Baker 2006 Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses Mol Ther 13 683 693 10.1016/j.ymthe.2005.11.013 1:CAS:528:DC%2BD28XjtFOktL0%3D 16387552
15. KH Warrington Jr OS Gorbatyuk JK Harrison SR Opie S Zolotukhin N Muzyczka 2004 Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus J Virol 78 6595 6609 10.1128/JVI.78.12.6595-6609.2004 1:CAS:528:DC%2BD2cXkvVCjtr4%3D 15163751 (Pubitemid 38715956)
16. Q Yang M Mamounas G Yu S Kennedy B Leaker J Merson F Wong-Staal M Yu JR Barber 1998 Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy Hum Gene Ther 9 1929 1937 10.1089/hum.1998.9.13-1929 1:CAS:528:DyaK1cXlslKnsLw%3D 9741431
17. Z Wu A Asokan RJ Samulski 2006 Adeno-associated virus serotypes: vector toolkit for human gene therapy Mol Ther 14 316 327 10.1016/j.ymthe.2006.05.009 1:CAS:528:DC%2BD28XotFylu7o%3D 16824801 (Pubitemid 44184972)
18. H Buning L Perabo O Coutelle S Quadt-Humme M Hallek 2008 Recent developments in adeno-associated virus vector technology J Gene Med 10 717 733 10.1002/jgm.1205 18452237 (Pubitemid 352003915)
19. N Maheshri JT Koerber BK Kaspar DV Schaffer 2006 Directed evolution of adeno-associated virus yields enhanced gene delivery vectors Nat Biotechnol 24 198 204 10.1038/nbt1182 1:CAS:528:DC%2BD28XhtFGqs74%3D 16429148 (Pubitemid 43221704)
20. D Grimm JS Lee L Wang T Desai B Akache TA Storm MA Kay 2008 In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses J Virol 82 5887 5911 10.1128/JVI.00254-08 1:CAS:528:DC%2BD1cXnt1Chur8%3D 18400866 (Pubitemid 351822263)
21. Koerber JT, Jang JH, Schaffer DV (2008) DNA shuffling of adeno-associated virus yields functionally diverse viral progeny. Mol Ther 16:1703-1709
22. Li W, Asokan A, Wu Z, Van Dyke T, Diprimio N, Johnson JS, Govindaswamy L, Agbandje-McKenna M, Leichtle S, Eugene Redmond Jr D, McCown TJ, Petermann KB, Sharpless NE, Samulski RJ (2008) Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles. Mol Ther 16:1252-1260
23. I Kwon DV Schaffer 2008 Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer Pharm Res 25 489 499 10.1007/s11095-007-9431-0 1:CAS:528: DC%2BD1cXivFOiuro%3D 17763830
24. L Perabo H Buning DM Kofler MU Ried A Girod CM Wendtner J Enssle M Hallek 2003 In vitro selection of viral vectors with modified tropism: the adeno-associated virus display Mol Ther 8 151 157 10.1016/S1525-0016(03)00123-0 1:CAS:528:DC%2BD3sXkvFGmsrs%3D 12842438 (Pubitemid 36939306)
25. SJ White SA Nicklin H Buning MJ Brosnan K Leike ED Papadakis M Hallek AH Baker 2004 Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors Circulation 109 513 519 10.1161/01.CIR. 0000109697.68832.5D 1:CAS:528:DC%2BD2cXms1agsA%3D%3D 14732747 (Pubitemid 38168515)
26. M Sena-Esteves JA Hampl SM Camp XO Breakefield 2002 Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors J Gene Med 4 229 239 10.1002/jgm.276 12112640 (Pubitemid 40268359)
27. Hiroaki Wakimoto SK, Farrell CJ, Curry WT Jr, Zaupa C, Aghi M, Kuroda T, Stemmer-Rachamimov A, Liu T-C, Jeyaretna DS, Debasitis J, Shah K, Pruszak J, Martuza RL, Rabkin SD (in Press) Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res 69:3472-3481
28. CE Walsh JM Liu X Xiao NS Young AW Nienhuis RJ Samulski 1992 Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector Proc Natl Acad Sci USA 89 7257 7261 10.1073/pnas.89.15.7257 1:CAS:528:DyaK38XlsVCmsLg%3D 1323131
29. ML Broekman LA Comer BT Hyman M Sena-Esteves 2006 Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain Neuroscience 138 501 510 10.1016/j.neuroscience.2005.11.057 1:CAS:528:DC%2BD28XhvVWrsLk%3D 16414198 (Pubitemid 43255560)
30. G Gao MR Alvira S Somanathan Y Lu LH Vandenberghe JJ Rux R Calcedo J Sanmiguel Z Abbas JM Wilson 2003 Adeno-associated viruses undergo substantial evolution in primates during natural infections Proc Natl Acad Sci USA 100 6081 6086 10.1073/pnas.0937739100 1:CAS:528:DC%2BD3sXjvFOltLc%3D 12716974 (Pubitemid 36576934)
31. JP Mayginnes SE Reed HG Berg EM Staley DJ Pintel GE Tullis 2006 Quantitation of encapsidated recombinant adeno-associated virus DNA in crude cell lysates and tissue culture medium by quantitative, real-time PCR J Virol Methods 137 193 204 10.1016/j.jviromet.2006.06.011 1:CAS:528: DC%2BD28XpvV2ntL8%3D 16860883 (Pubitemid 44397158)
32. B Hauck W Xiao 2003 Characterization of tissue tropism determinants of adeno-associated virus type 1 J Virol 77 2768 2774 10.1128/JVI.77.4.2768-2774. 2003 1:CAS:528:DC%2BD3sXpvVGrsg%3D%3D 12552020 (Pubitemid 36222804)
33. Maguire CA, Meijer DH, Leroy SG, Tierney LA, Broekman ML, Costa FF, Breakefield XO, Stemmer-Rachamimov A, Sena-Esteves M (2008) Preventing growth of brain tumors by creating a zone of resistance. Mol Ther 16:1695-1702
34. WP Stemmer 1994 Rapid evolution of a protein in vitro by DNA shuffling Nature 370 389 391 10.1038/370389a0 1:CAS:528:DyaK2cXlvFOjsrs%3D 8047147 (Pubitemid 24259765)
35. A Kern K Schmidt C Leder OJ Muller CE Wobus K Bettinger CW Von der Lieth JA King JA Kleinschmidt 2003 Identification of a heparin-binding motif on adeno-associated virus type 2 capsids J Virol 77 11072 11081 10.1128/JVI.77.20.11072-11081.2003 1:CAS:528:DC%2BD3sXotFOgur0%3D 14512555 (Pubitemid 37204297)
36. P Wu W Xiao T Conlon J Hughes M Agbandje-McKenna T Ferkol T Flotte N Muzyczka 2000 Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism J Virol 74 8635 8647 10.1128/JVI.74.18.8635-8647.2000 1:CAS:528:DC%2BD3cXmsVant7g%3D 10954565 (Pubitemid 30666714)
37. P Ward CE Walsh 2009 Chimeric AAV cap sequences alter gene transduction Virology 386 237 248 10.1016/j.virol.2009.01.012 1:CAS:528:DC%2BD1MXjvVyqs7g%3D 19232422
38. CN Cearley LH Vandenberghe MK Parente ER Carnish JM Wilson JH Wolfe 2008 Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain Mol Ther 16 1710 1718 10.1038/mt.2008.166 1:CAS:528:DC%2BD1cXhtFGhs7bN 18714307
39. CN Cearley JH Wolfe 2006 Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain Mol Ther 13 528 537 10.1016/j.ymthe.2005.11.015 1:CAS:528:DC%2BD28Xhslykt78%3D 16413228 (Pubitemid 43257620)
40. D Sondhi NR Hackett DA Peterson J Stratton M Baad KM Travis JM Wilson RG Crystal 2007 Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh. 10 rhesus macaque-derived adeno-associated virus vector Mol Ther 15 481 491 10.1038/sj.mt.6300049 1:CAS:528:DC%2BD2sXhtVKiu7fI 17180118 (Pubitemid 46306590)